Skip to main content
. Author manuscript; available in PMC: 2025 Jan 12.
Published in final edited form as: J Natl Compr Canc Netw. 2024 Jul 12;22(6):e247012. doi: 10.6004/jnccn.2024.7012

Table 1.

Baseline Characteristics

N % PCS Mean (SD) P value MCS Mean (SD) P value
TOTAL 3,497 43.6 (11.9) 46.7 (10.7)
Tumor Type
 Breast 712 20 50.8 (9.3) <0.001 46.3 (10.4) <0.001
 Sarcoma 448 13 39.7 (12.1) 48.3 (10.8)
 Leukemia 366 11 41.7 (10.7) 47.4 (10.2)
 Hodgkin’s Lymphoma 287 8.2 45.1 (11.1) 48.0 (10.3)
 Non-Hodgkin’s Lymphoma 284 8.1 42.3 (12.2) 46.4 (10.7)
 Germ Cell Tumor 226 6.5 44.0 (10.9) 47.7 (10.1)
 Colorectal 215 6.2 41.0 (12.1) 46.0 (11.2)
 Central Nervous System 128 3.7 43.9 (10.2) 46.9 (10.9)
 Cervical 120 3.4 42.3 (13.2) 42.8 (11.6)
 Other 711 20 40.7 (11.9) 45.9 (11.2)
Age at diagnosis
 Adolescent (15–18 years) 205 5.9 42.0 (11.4) <0.001 49.4 (11.1) <0.001
 Emerging Adult (19–25 years) 629 18 42.1 (12.1) 48.1 (10.6)
 Young Adult (26–39 years) 2,663 76 44.1 (11.8) 46.2 (10.7)
Gender
 Female 2,006 57 44.5 (11.9) <0.001 45.6 (10.7) <0.001
 Male 1,491 43 42.5 (11.7) 48.2 (10.6)
Race/ Ethnicity
 White 2,248 64 44.1 (11.9) <0.001 46.7 (10.7) 0.26
 Hispanic 657 19 43.2 (11.8) 46.1 (11.0)
 Black 345 9.9 41.2 (11.9) 47.4 (11.0)
 Other 247 7.1 43.9 (11.4) 47.0 (10.2)